These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12855637)

  • 1. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
    Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
    Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
    Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
    Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
    Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
    Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
    Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.
    Wang W; Tang Y; Li J; Jiang L; Jiang Y; Su X
    Cancer Cytopathol; 2015 Feb; 123(2):117-22. PubMed ID: 25529354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of combined determination of serum and pleural effusion level of CEA,CYFRA21-1, TPS in the diagnosis of lung cancer].
    Huang F; Wang XL; Yang L; Yin BX; Geng Y; Li TT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):370-2. PubMed ID: 18394347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.
    Di Carlo A; Mariano A; Terracciano D; Mazzarella C; Galzerano S; Cicalese M; Cecere C; Macchia V
    Oncol Rep; 2007 Aug; 18(2):425-31. PubMed ID: 17611666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tumor marker CYFRA 21-1 in the diagnostics of NSCLC lung cancer.
    Pavićević R; Milicić J; Bubanović G; Supe S
    Coll Antropol; 1998 Dec; 22(2):629-35. PubMed ID: 9887620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.
    Son SM; Han HS; An JY; Choe KH; Lee KM; Lee KH; Kim SS; Lee YM; Lee HC; Song HG; Lee OJ
    Pathology; 2015 Feb; 47(2):123-9. PubMed ID: 25551300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of CYFRA 21-1, HER-2/neu and NSE in differential diagnosis of pleural effusion].
    Lin H; Qiu SY; Sun SH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):767-70. PubMed ID: 20619104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.
    Pellegrini C; Falleni M; Marchetti A; Cassani B; Miozzo M; Buttitta F; Roncalli M; Coggi G; Bosari S
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3645-52. PubMed ID: 14506153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer.
    Su WP; Chen YT; Lai WW; Lin CC; Yan JJ; Su WC
    Lung Cancer; 2011 Jan; 71(1):28-33. PubMed ID: 20430468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.